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Cutaneous sensory nerves mediate inflammation and
wound healing by the release of neuropeptides such as
substance P. Neutral endopeptidase is a cell surface
enzyme that degrades substance P and thereby termin-
ates its biologic actions. The distribution of neutral
endopeptidase in normal skin and wounded human
skin, however, has not been examined. The objectives
of this study were to evaluate neutral endopeptidase
expression in wounded and unwounded skin as well
as in cells derived from human skin. Neutral endopepti-
dase was strikingly localized in normal skin by
immunohistochemistry to keratinocytes of the epi-
dermal basal layer, to hair follicles, eccrine and seba-
ceous glands as well as to endothelium of blood vessels
and to large nerves. Standard incisional human wounds
were studied at several time points between 1 h and 28 d
after wounding. Staining for neutral endopeptidase was
noted in the wound bed 6 h after wounding. In contrast
to normal skin, staining of all the epidermal cell layers
The cutaneous sensory nervous system comprises anetwork of fine C fibers within the skin that innervatemultiple cell types and plays an important role ininflammation and wound healing (Hosoi et al, 1993;Ansel et al, 1996). These fibers convey information
from the skin to the central nervous system, and thus have a sensory
role. In addition, they have a local effector function by releasing
neurotransmitters within the skin (Foreman and Jordan, 1984).
Neuropeptides, notably substance p (SP) and calcitonin gene
related peptide are released from afferent fibers both centrally and
peripherally (Holzer, 1988). SP and calcitonin gene related peptide
have multiple actions within the skin that are important in
inflammation and healing (Otsuka and Yoshioka, 1993). These
actions include increasing blood flow (Lembeck and Holzer, 1979),
inducing plasma extravasation (Iwamoto et al, 1989) and neutrophil
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was noted in the migrating tongue of epithelium in
l d wounds. Similar full-thickness staining was noted
in 3 d and 7 d wounds in all layers of the new wound
epithelium and in a ‘‘transition epithelium’’ near the
wound edge. By 28 d post wounding neutral endopep-
tidase staining again was detected only in the basal
layer of the epidermis. Neutral endopeptidase mRNA
was detected in normal skin and wounds as well as
cultured keratinocytes, fibroblasts and endothelial
cells. Neutral endopeptidase enzymatic bioactivity was
demonstrated in cultured keratinocytes. While it is
known that several metalloproteinases important to
tissue repair are produced by keratinocytes, this is
the first evidence that keratinocytes produce neutral
endopeptidase. Neutral endopeptidase may terminate
the proinflammatory and mitogenic actions of neuro-
peptides in normal skin and wounds. Keywords: endothel-
ial cells/epidermis/fibroblasts/hair follicles/keratinocytes/




hle´n et al, 1989), stimulating adhesion molecule
expression by endothelial cells (Matis et al, 1990; Quinlan et al,
1998) and macrophage chemotaxis (Ruff et al, 1985), stimulating
DNA synthesis by keratinocytes (Tanaka et al, 1988) and fibroblasts
(Nilson et al, 1985) as well as stimulating proliferation by endothelial
cells and inducing neovascularization (Ziche et al, 1990). These
effects require local secretion and are mediated by interaction with
specific G-protein coupled receptors on target cells.
The biologic actions of neuropeptides are rapidly attenuated to
prevent prolonged stimulation of cells in an uncontrolled manner
(Bohm et al, 1997). One of the earliest mechanisms of attenuation
is degradation of the neuropeptide within the extracellular fluid.
Neutral endopeptidase (NEP, EC 3.4 24.11), also known as
enkephalinase, common acute lymphoblastic antigen (CALLA) and
CD10 is a cell surface enzyme that degrades several neuropeptides
(Roques et al, 1993). From a kinetic standpoint, SP and bradykinin
are favorable substrates (Matsas et al, 1984), although NEP also
degrades calcitonin gene related peptide (Katayama et al, 1991).
Thus, NEP inactivates several proinflammatory peptides and thereby
terminates inflammation. Administration of NEP inhibitors magni-
fies the proinflammatory effects of SP and other tachykinin in
several tissues (Nadel, 1990; Roques et al, 1993). Furthermore,
genetic deletion of NEP results in elevated plasma extravasation in
multiple tissues including the skin (Lu et al, 1997). These effects
are reversed by administration of selective antagonists of SP and
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bradykinin receptors and thus the observed effects are mediated by
diminished degradation of these peptides.
Tissue responsiveness to neuropeptides depends on the presence
of specific receptors and on the distribution of neuropeptide
degrading enzymes such as NEP. NEP is highly expressed in the
brush border of the kidney and small intestine, and in lymph nodes,
although substantial NEP levels are also found in the brain, salivary
glands, adrenal glands, pancreas, gut wall, nasal mucosa, and lungs
(Roques et al, 1993; Ansel et al, 1996). The skin also contains
neuropeptide degrading proteases, although they have not been
fully characterized and localized. Frog skin secretes a 100 kDa
prototypical metallopeptidase that degrades neuropeptides but
which is distinct from NEP (Carvalho et al, 1992). Homogenized
mouse skin (Paus et al, 1994) and guinea pig skin (Iwamoto et al,
1989) have peptidase activity that can be blocked with specific
inhibitors of NEP. A previous study of human skin has failed to
demonstrate NEP by immunohistochemistry (IHC) in a patient
with scleroderma. Cultured skin fibroblasts from the same patient,
however, did express NEP measured by flow cytometry (Bou-
Gharios et al, 1995).
In view of the lack of information about localization of NEP in
the skin, and the established role of neuropeptides in cutaneous
inflammation and in wound healing, we decided to study in detail
the distribution of NEP in normal and wounded human skin. Our
aims were to: (i) localize NEP in normal and wounded human
skin by IHC using a specific antibody; (ii) examine expression of
NEP mRNA in normal human skin, in wounds and in cells derived
from the human skin; and (iii) confirm expression of enzymatically
active NEP in keratinocytes.
MATERIALS AND METHODS
Generation of an antibody to NEP An antibody was raised in rabbits
to recombinant human NEP (Khepri Pharmaceutical, San Francisco, CA)
conjugated to keyhole limpet hemocyanin (KLH) (Calbiochem, La Jolla,
CA). The recombinant human NEP was produced in Chinese hamster
ovary (CHO) cells. This human NEP was shown to be enzymatically
active using the fluorometric assay described in Materials and Methods below.
The NEP (5 mg) was dissolved in 3 ml 50 mM phosphate-buffered saline
(PBS), pH 7.4, containing 5 mg KLH, 30 mg carbodiimide (ICN, CA).
The mixture was agitated at room temperature for 3 h and overnight at
4°C. The efficacy of conjugation, estimated by incorporation of iodinated
NEP (labeled using chloramine T) was ~30%. Three 10 wk old New
Zealand rabbits were immunized at intervals of 6–8 wk by multiple
intradermal injections. Emulsions were prepared of equal parts of conjugated
antigen and complete Freund’s adjuvant (Difco Labs, Detroit, MI). Each
rabbit received 2 ml of emulsion, containing 500 µg conjugate, divided
into 12–15 sites. At the first immunization, 0.5 ml Tri-immunol vaccine
(Lederle Labs, Pearl River, NY) was injected intramuscularly. Useful
antibodies were obtained after the second boost. All rabbits generated
antibodies with titers of ~1:10,000, as determined by ELISA. Affinity
column purification was performed with recombinant NEP.
Western blots: [Enhanced chemiluminescence (ECL)] Total protein
from homogenized adult human skin, cultured adult human keratinocytes,
and cultured fetal human keratinocytes (human keratinocytes) was extracted
in urea–Tris (Fleckman et al, 1997) and centrifuged. The protein concentra-
tion of the supernatants was determined for each sample, then 15 µg of
protein was loaded and separated by discontinuous sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (Laemmli, 1970). Purified recombinant
NEP (1 µg total protein) was also fractionated by sodium dodecyl
sulfate–polyacrylamide gel electrophoresis. Proteins were electrophoretically
transferred to 0.2 µm nitrocellulose membranes (Bio-Rad, Hercules, CA)
(Towbin et al, 1979). The membranes were incubated with antibodies to
NEP at 1:500 dilution or pan keratin AE1/AE3 at 1:200/1:1000 dilution
(gift T.T. Sun) (Cooper and Sun, 1986) for 1 h at room temperature.
Membranes were washed and incubated with secondary antibodies. Second-
ary antibody for NEP was biotinylated goat anti-rabbit–horseradish peroxid-
ase (Bio-Rad) and secondary antibody for AE1/AE3 was biotinylated goat
anti-mouse–horseradish peroxidase (BioRad), each at 1:2000 dilution with
a 1 h incubation. All washes used 2% dried milk, 0.1% Tween in PBS.
Blots were exposed on autoradiography film then visualized using ECL
detection reagents (Amersham, Arlington Heights, IL).
Tissue collection for IHC Simplate-II (General Diagnostics Company,
Organon Teknika, Durham, NC) bleeding time devices were used to
create pairs of wounds on both legs of 11 normal males and three normal
female volunteers 66 6 6 y of age (mean 6 SD). The Simplate-II is a
spring-loaded instrument which, when activated, projects a pair of blades
5 mm in length, 1 mm in depth, and 3 mm apart. This human wound
model has been described previously in detail (Olerud et al, 1995).
Volunteers were recruited using methods approved by the University of
Washington Institutional Review Board for Human Subjects and with
informed consent. All subjects were screened and shown to be free of
neuropathy and diabetes mellitus as previously described (Olerud et al, 1995).
Pairs of wounds were collected with a 4 mm biopsy punch at 1 h, 6 h,
1 d, 3 d, 7 d, 14 d, and 28 d after injury. Wounds were created and
collected such that each time point was represented in four or five subjects.
All 14 subjects contributed unwounded control samples from both legs
and one sample from thigh, sacrum, or medial arm to test for regional
variation in innervation and NEP expression. Half of each biopsy was
frozen in OCT (Tissue Tek Miles, Torrance, CA) for IHC studies.
To examine more thoroughly NEP immunohistochemistry in hair
follicles a single 6 mm biopsy was taken from the vertex scalp of a 53 y
old volunteer with mild androgenetic alopecia. The cylindrical biopsy was
bisected and mounted in OCT in order to obtain sections perpendicular
to the epidermis (vertical sections) as well as sections parallel to the
epidermis (horizontal sections). Parallel sections were taken below the
dermal–epidermal junction at depths between 1 and 2 mm.
A sample of human jejunum was taken after informed consent from
redundant tissue excised during cancer surgery. The specimen was immedi-
ately frozen in OCT and used as a positive control for IHC studies of
NEP because of the high level of NEP found in the intestinal brush boarders.
Immunohistochemistry Six micron frozen tissue sections of wounds
and control skin washed in 0.05 M Tris-buffered saline were postfixed
with 2% paraformaldehyde/Sorensons buffer for 5 min. The slides were
then washed with 20 mM glycine in Tris-buffered saline to saturate any
free aldehydes and incubated in H2O2/Tris-buffered saline for 30 min.
Slides were incubated in 1.3% goat serum/Tris-buffered saline for 30 min
and then incubated with NEP anti-serum at 1:200 dilution for 1 h at room
temperature. Control slides were either incubated without primary antibody
or with NEP antibody at 1:200 adsorbed with recombinant NEP at a
concentration of 10 µg per ml. Biotinylated goat anti-rabbit antibody
(Vector Laboratories, Burlingame, CA) at 1:200 dilution for 30 min was
used as secondary antibody, followed by streptavidin–biotin complex
(SABC Universal Kit, Zymed Laboratories, San Francisco, CA) at 1:200
dilution for 30 min. All antibodies were diluted with 0.1% bovine serum
albumin in Tris-buffered saline and all incubations were done at room
temperature. Sections were then visualized for immunoreactivity using 3,39
diaminobenzidine (Sigma, St. Louis, MO) as a chromogen (0.12% in H2O
with 0.1% H2O2 and 20% 0.5 M Tris buffer for 20 min), coverslipped
with glycergel (Dako, Carpenteria, CA) and photographed using a Nikon-
Microphot-SA microscope using either standard image capture or differen-
tial interference contrast image capture.
Tissue collection for RNA isolation For studies of mRNA in normal
skin and wounds a 53 y old subject allowed pairs of wounds 1, 3, and 7 d
of age to be created on the leg with a Simplate-II bleeding time device.
These wounds were removed with a 6 mm biopsy punch and immediately
frozen in liquid nitrogen. Two biopsies of adjacent unwounded skin were
likewise taken and immediately frozen in liquid nitrogen. Total RNA was
extracted with Trizol (Gibco, Gaithersburg, MD) for mRNA studies. The
subject met the same entry criteria as the other volunteers with regard to
the absence of diabetes and neuropathy.
Detection of NEP mRNA in normal skin, wounds, and cultured
newborn human keratinocytes by reverse transcriptase–polymerase
chain reaction (PCR) Skin and wound extracts were studied using
oligonucleotide primers synthesized (Gibco) corresponding to bp 903–
921 (59 primer, sense-ATG ACA TTG GCC CAG ATC C) and the
complementary reverse sequence against base pairs 1330–1311 (39 GCA
ATC AAA TCC TCG ACC AC). The melting temperature of the primers
is 46°C. RNA was extracted with Trizol (Gibco) from a pair of 6 mm
punch biopsies of normal skin from the lateral leg (day 0) as well as the
day 1, 3, and 7 wound specimens. Reverse transcriptase–PCR was
performed using Super Script One-Step reverse transcriptase–PCR System
(Gibco). Synthesis of cDNA was performed at 50°C for 30 min followed
by PCR using a denaturing temperature of 94°C and an annealing
temperature of 58°C and an extension temperature of 72°C for 30 cycles.
Included were samples treated with RNase to control for the possibility
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of a PCR product generated from genomic DNA and samples were
tested for consistent levels of glyceraldehyde-3-phosphate dehydrogenase
expression.
RNA was isolated from cultured newborn human keratinocytes using
Ultraspec RNA Isolation Reagent (Biotex Labs, Alberta, Canada). Oligo-
nucleotide primers were synthesized (Bio-Synthesis, Lewisville, TX) corres-
ponding to base pairs 461–481 (59 primer, sense-CCT CTA CTC AAA
CTG TTA CC) and the complementary reverse sequence against base
pairs 754–774 (39 primer, anti-sense-GT CTA ACT AAG CAG TCC
TTC) of NEP cDNA (Malfroy et al, 1988). Reverse transcription was
performed on keratinocyte RNA to make a complementary cDNA strand
to NEP mRNA by combining 39 primer, Maloney murine leukemia virus
reverse transcriptase (MMLV RT, Gibco), 1 OX d4NTP (Pharmacia LKB
Biotechnology, Piscataway, NJ), 5 3 first strand buffer (Gibco), RNasin
(Promega, Madison, WI), and dithiothreitol (Gibco). Reverse transcriptase
mixture was incubated at 42°C for 1 h followed by heat inactivation of
the MMLV RT at 65°C. PCR was performed on 0, 1, 2, and 5 µl of the
preconfluent and confluent reverse transcriptase reaction products by adding
equal amounts of the 39 and 59 primers, 1.25 3 d4NTP mixture (Pharmacia
LKB Biotechnology) and 1 OX PCR buffer 1 Mg (Boehringer Mannheim,
Indianapolis, IN). Taq polymerase (Boehringer Mannheim) was added
during the hot start at 85°C. The PCR reaction was carried out for 35
cycles using a denaturing temperature of 94°C, an annealing temperature
of 53°C, and extension temperature of 72°C.
The reverse transcriptase–PCR products from extracts of normal skin
and wound as well as from keratinocytes were gel-purified (Qiagen,
Valencia, CA). The products were then sequenced in both directions using
a PCR sequencing reaction containing the 59 and 39 NEP oligonucleotide
primer and Dye Terminator with AmpliTaq DNA Polymerase FS (ABI
Prism, Perkin-Elmer, CT) followed by sequencing using a model 377
Fluorescence Sequencer (ABI Prism, Perkin-Elmer).
Northern blot analysis Northern blot analysis was performed using
total RNA extracted from 3 and 7 d wounds with Trizol (Gibco). RNA
was hybridized to a NEP specific ((32P) UTP-labeled anti-sense RNA
probe (Plowman et al, 1993) transcribed from base pairs 945–1346 in the
NEP cDNA sequence. Ten and 20 µg samples of total RNA were studied.
Normalization of the data for variability in gel loading and transfer efficiency
was accomplished by staining the RNA with 0.5 M NaOAc/0.04%
methylene blue.
Newborn human keratinocytes (Dale et al, 1990), human dermal
fibroblasts (HDF) (Dale et al, 1990), or human dermal microvascular
endothelial cells (HDMEC) (Swerlick et al, 1991) were cultured in
appropriate media to 50%, 70%, or 90% confluence, respectively, then
subcultured in serum-free media overnight before mRNA isolation. Cells
were harvested with or without 100 nM SP for 3 h and mRNA was
isolated using a commercially available mRNA Isolation Kit (Boehringer
Mannheim). Northern blot analysis was performed as previously described
(Sambrook et al, 1989). An 860 bp NEP cDNA fragment probe isolated
by reverse transcriptase–PCR was radiolabeled according to the random
priming method of Feinberg and Vogelstein (1983, 1984). The cDNA
fragment used for northern blotting spanned base pairs 101–961. Identity
with the published sequence for NEP cDNA (Malfroy et al, 1988) was
established by DNA sequencing. The positively charged nylon membrane
blot was probed at 65°C for 3–4 h in Rapid-hyb buffer (Amersham) and
washed with low stringency solution (2 3 sodium citrate/chloride buffer,
0.1% sodium dodecyl sulfate) at room temperature then high stringency
solution (0.1 3 sodium citrate/chloride buffer, 0.1% sodium dodecyl
sulfate) at 65°C for 20 min prior to exposure to X-ray film at 70°C for
2–3 d. Normalization of the data for variability in gel loading and transfer
efficiency was accomplished by determining the level of β-actin using the
appropriate cDNA probe (Alonso et al, 1986).
NEP enzymatic assay Frozen keratinocytes were weighed and homo-
genized in 50 mM Tris (hydroxymethyl) aminomethane hydrochloride
(Tris, pH 7.5) containing 1 µM pepstatin A and 1 mM phenylmethyl-
sulfonylfluoride, and assayed for protein using Coomassie Blue. Cell
membranes containing a variety of enzymes (presumably including NEP)
were incubated with Glu-Ala-Ala-Phe-MNA. Enzymatic degradation of
Glu-Ala-Ala-Phe-MNA results in a fluorescent product (MNA) that can
be quantitated. Incubations with keratinocyte membranes were carried out
both with and without the specific inhibitor of NEP (DL-thiorphan). The
difference in the production of MNA, between membrane preparations
with the specific inhibitors of NEP and those without, were attributed to
NEP enzymatic activity. The enzymatic activity is reported in picomoles
of MNA generated per hour per microgram of protein (Terashima
et al, 1992).
Figure 1. Western blot shows specific staining for NEP without
keratin antibody contamination of the polyclonal NEP anti-serum.
Lane A loaded with NEP shows a single positive band at approximately
94 kDa when tested with the polyclonal antibody to NEP, but showed no
evidence of contamination with antibodies to keratins when tested on
newborn keratinocytes (lane B) and whole adult skin (lane C). Lanes D
(newborn keratinocytes), E (adult keratinocytes), and F (whole adult skin)
stained positively for multiple keratin bands using the keratin antibodies
AE 1 and AE 3. AE 1 and AE 3 did not show positive bands on lanes
loaded with NEP (data not shown).
RESULTS
NEP antibody shows specificity for NEP without keratin
antibody contamination We examined the specificity of the
NEP antibody by western blotting. The antibody specifically
interacted with recombinant NEP demonstrating a single positive
band with an apparent molecular mass of approximately 94 kDa
(Fig 1, lane A). Anti-sera are often contaminated with antibodies
to keratin. It is thus important to confirm that the NEP anti-serum
did not interact with keratins. The NEP anti-serum did not interact
with proteins corresponding to keratins (40–65 kDa) in extracts
from human keratinocytes or whole human skin extracts (Fig 1,
lanes B and C). NEP was not detected by western blot in
keratinocyte or whole skin extracts presumably due to low expres-
sion or the fact that NEP is primarily membrane bound and thus
not extracted. As a positive control, the cytokeratin antibodies AE1
and AE3 showed binding with multiple bands in the keratin range
(40–65 kDa) for cultured newborn human keratinocytes, adult
human keratinocytes, and adult human skin homogenates (lanes D,
E, and F, respectively). Thus, the NEP anti-serum specifically
detects recombinant human NEP and is not contaminated with
cytokeratin antibodies.
NEP is highly expressed in the brush border of the small intestine.
Therefore, we stained human intestine to verify that we could
detect NEP in this location. NEP immunoreactivity was highly
expressed in the brush border (Fig 2, NEP antibody). Staining
was abolished by preadsorbtion of the NEP anti-serum with
recombinant NEP (Fig 2, control A). Thus, the NEP anti-
serum detected NEP in tissue sections with specificity and at the
predicted location.
IHC shows NEP staining in normal skin Immunoreactive
NEP was highly expressed in the basal layer of unwounded human
skin (Fig 3). The staining of basal keratinocytes appeared to be
cytoplasmic and cell membrane associated. This pattern was consist-
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Figure 2. Intestine stains positively with NEP antibody. The strong
NEP staining of the brush border of intestine (large arrows) was used as a
positive control for antibody reactivity. Control A: NEP antibody
preadsorbed with recombinant NEP shows no staining of the brush border.
Control B: IHC without NEP antibody shows no staining of the brush
border. Small arrow indicates nonspecific immunoperoxidase reactivity
(possibly mast cells).
Figure 3. Unwounded human skin stains positively with NEP
antibody. Low and high magnification using (differential interference
contrast image capture) showing strong NEP staining in the basal layer of
unwounded epidermis (indicated by large arrows). Controls A and B are as
indicated in Fig 2. Small arrows indicate melanin staining in epidermis.
ent for all 14 subjects regardless of skin region (legs, thighs, arms,
and sacrum). Preadsorbtion with recombinant NEP (Fig 3, control
A) or omission of the NEP antibody (control B) abolished staining.
Other cutaneous structures noted to be stained by the NEP anti-
serum were cutaneous glands, particularly eccrine glands, blood
vessels, and nerves (Fig 4). The epithelial cells of the sweat ducts
were most prominently stained, but staining of the myoepithelial
cells of the glands was also observed. Blood vessels showed NEP
staining which was more faint than the epithelial staining in most
subjects. In some subjects, there was dramatic NEP staining of the
dermal vessels, particularly in the papillary dermis. Both endothelial
cells and pericytes appeared stained. The large nerves of the dermis
appeared stained in perineural tissue and, in a patchy pattern, within
the nerve bundle itself. The nerve filaments in the papillary dermis
and the epidermis showed no staining.
A biopsy from normal scalp with mild androgenetic alopecia
revealed prominent NEP staining of the follicular epithelium. Using
standard definitions of follicle morphology (Headington, 1984)
terminal follicles had positive staining of the connective tissue
sheath of the perifolliculum and the outer root sheath. The cells
Figure 4. Eccrine glands, nerves, and blood vessels show NEP
staining. Eccrine glands show strong NEP staining. The blood vessel
shows a weaker NEP staining (arrows). The perineural sheath of a large
nerve in the reticular dermis shows moderate NEP staining (arrows) and
patchy staining is seen in the nerve bundle as well. Controls: NEP antibody
preadsorbed with recombinant NEP.
Figure 5. Hair follicles stain for NEP. (a) Horizontal section of terminal
follicle: NEP staining of perifolliculum (large arrow) and outer root sheath
(small arrow) (b) Horizontal section of vellus follicle. NEP staining of the
perifolliculum (large arrow), outer root sheath (small arrow), and Huxleys’
layer of the inner root sheath (*), and (c) vertical section of a follicle. NEP
staining of the hair matrix (*), dermal papillae (small arrow), and follicular
stela (large arrow).
of the inner root sheath, including both Henle’s and Huxley’s layer,
were not immunoreactive for NEP. Vellus follicles also demonstrated
NEP staining in the connective tissue sheath and the outer root
sheath, but in contrast to the terminal follicles, showed positive
staining of Huxley’s layer of the inner root sheath. This differential
staining pattern is demonstrated in terminal (Fig 5a) versus vellus
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Figure 6. Partial thickness human
wounds show changes in the
distribution of NEP staining from 1 h
to 28 d after wounding. One hour
wounds show a freshly cut wound edge
with no epidermal migration and no
staining of the wound matrix but positive
staining in the basal cells of the epidermis
adjacent to the wound (arrows). The
arrowhead indicates the cut edge of the
wound. Six hour wounds show no
migrating wound epidermis, but positive
staining in the wound matrix and positive
staining in the basal cells of the epidermis
adjacent to the wound. Three day wounds
and 7 d show diffuse NEP staining
throughout the wound epithelium, in the
epidermis adjacent to the wound
(‘‘transition epithelium’’) and in the wound
matrix. Fourteen day wounds show diffuse
staining throughout the wound epithelium
and wound matrix; however, the epidermis
adjacent to the wound shows primarily
basal cell staining. Twenty-eight day
wounds show wound matrix staining and
basal staining of the wound epidermis, and
epidermis adjacent to the wound. Control
IHC without primary antibody.
follicles (Fig 5b) on horizontal sections. The NEP staining pattern
appeared to be the same in anagen and telogen follicles. Vertical
scalp sections revealed strong NEP staining of the hair matrix cells,
the dermal papillae and follicular stela (Fig 5c).
IHC shows NEP staining in wounds We then examined NEP
expression in experimental human wounds. The pattern of IHC
observed in wound tissue was consistent over all subjects studied
(Figs 6 and 7). In 1 h wounds, the basal pattern of NEP staining
extended to the cut edges of the wound. In 6 h wounds, the NEP
basal expression was present at the cut edge of the wound as well
as in the wound matrix. After 24 h, NEP staining of the epithelium
was noted on the migrating tongue of epithelium as well as in the
provisional wound matrix. In 3 d wounds, NEP staining occurred
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Figure 7. Higher magnification of the epidermis in a 7 d wound
shows a transitional pattern of staining for NEP. NEP staining is
diffuse throughout the wound epithelium and in the ‘‘transition epithelium’’
between wound and adjacent unwounded epithelium. It appears to resume
basal staining adjacent to the ‘‘transition epithelium’’ (arrowhead). The
epidermis beyond the ‘‘transition epithelium’’ shows basal cell staining
(small arrows). Arrowhead in control ‘‘transition epithelium’’ indicates
comparable region as in NEP antibody panel. Small arrows in control
adjacent epithelium indicates melanin staining.
throughout the full thickness of the epidermis distinct from the
basal pattern observed in unwounded epidermis. This full thickness
pattern of epidermal staining extended for approximately 30–50
cells lateral to the wound margin in a region that we called the
‘‘transition epithelium.’’ In 7 d wounds (Fig 7), the hypertrophic
wound epithelium expressed NEP throughout the epidermis and
the pre-existing wound margin showed expression of NEP through-
out the epidermis of the ‘‘transition epithelium.’’ The basal pattern
was observed lateral to the ‘‘transition epithelium.’’ By 14 d post-
wounding, the new wound epithelium still appeared to have
increased expression of NEP above the basal layer. After 28 d, the
basal pattern of NEP staining was re-established, although in some
wounds the eschar was not detached above the wound.
At each time point after 6 h, there was NEP staining within the
dermal wound bed that appeared to be largely noncellular. The
NEP staining initially appeared to be in the provisional wound
matrix and later, bound to pre-existing dermal collagen and elastin.
It is noteworthy that the 14 d and 28 d wounds had a considerable
number of fibroblasts in the papillary dermis. These cells, known
to be capable of expressing NEP, showed no significant staining.
NEP mRNA is detected in normal skin, wounds, and human
keratinocytes by reverse transcriptase–PCR NEP mRNA
was detected by reverse transcriptase–PCR in normal skin (day 0)
and from day 1, 3, and 7 wounds (Fig 8). A 408 bp cDNA product
was produced. DNA sequencing of the PCR product demonstrated
that it is identical with the known cDNA sequence for NEP (base
pairs 903–1311) (Malfroy et al, 1988). To confirm that NEP is
expressed by keratinocytes we used reverse transcriptase–PCR to
amplify a 313 bp cDNA product from subconfluent keratinocytes
and from confluent keratinocytes. DNA sequencing of the PCR
product demonstrated that this product is identical with the known
cDNA sequence for NEP (base pairs 461–774) (Malfroy et al,
1988) (Fig 9). Levels of glyceraldehyde-3-phosphate dehydrogenase
expression were used in all reverse transcriptase–PCR experiments
to confirm loading amounts were equivalent (data not shown).
NEP mRNA is detected in wounds, human keratinocytes,
HDF, and HDMEC by northern blot analysis NEP expression
in 3 d and 7 d wounds was also documented by northern blot
analysis (data not shown). The mRNA detected using a 401 bp
RNA antisense probe (base pairs 945–1346) produced exactly the
same size band 3.1 kb as observed for the cDNA probe used for
the human keratinocytes, HDF and HDMEC experiments (Fig 10).
Normal skin and day 1 wounds were not tested because less than
Figure 8. NEP mRNA is detected in skin and wounds by reverse
transcriptase–PCR. Lanes 2–5 show an approximately 400 bp product
corresponding to the expected NEP reverse transcriptase–PCR product of
408 bp (base pairs 903–1311).
20 µg of total RNA was extracted. We were unable to detect NEP
mRNA by northern analysis with 10 µg of total RNA in the 3 d
and 7 d wounds.
We used northern blotting to examine the relative expression of
NEP mRNA of skin derived cells in culture. As indicated in
Fig 10, NEP mRNA was detected using an 860 bp cDNA probe
(base pairs 101–961) in all three cell lines by a single band at 3.1 kb.
Our studies indicated that of the cell types, HDF by far expressed
the highest level of NEP mRNA compared with human ker-
atinocytes and HDMEC. The addition of 100 nM SP for 3 h
resulted in a modest increase in HDF NEP mRNA but little or
no change in human keratinocytes or HDMEC NEP mRNA
expression. Thus, these data demonstrate that NEP mRNA is
expressed in normal human epidermal and dermal cells.
NEP enzymatic activity is present in keratinocytes To
confirm than NEP expressed by keratinocytes is biologically active
we measured NEP activity using a fluorescent substrate degradation
assay. Homogenized human keratinocytes demonstrated NEP
enzymatic activity of 37.76 pmol of MNA per h per µg. The
activity is specific for NEP as DL-thiorphan inhibited the enzymatic
activity. Whereas this activity is clearly above baseline, it represents
only approximately 1/20 the activity which has been measured in
jejunal mucosa using the same method (Bunnett et al, 1993).
DISCUSSION
In this paper we have documented that NEP is expressed in the
epidermis by keratinocytes. Several lines of evidence were used to
document that keratinocytes express NEP. First, NEP was detected
by IHC in the epidermis of normal human skin and wounds.
Second, both reverse transcriptase–PCR and northern blot methods
demonstrated that cultured keratinocytes transcribe NEP mRNA.
Third, an enzymatic assay showed specific NEP activity in cultured
keratinocytes, although at a lower level than previously measured
for jejunum using the same method (Bunnett et al, 1993).
It is not surprising that NEP is expressed by epidermis and
epidermal appendages. The skin is richly innervated and these
epidermal structures have been shown to contain thin nerve fibers
(Hilliges et al, 1995) which immunolabel for neuropeptides (Levy
et al, 1992; Hosoi et al, 1993). NEP is the major SP degrading
enzyme and it degrades other neuropeptides, such as calcitonin
gene related peptide, known to play an important part in cutaneous
neuroinflammation (Katayama et al, 1991). Other densely innervated
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Figure 9. NEP mRNA is detected in cultured human keratinocytes
by reverse transcriptase–PCR. Lanes 2 and 6 show no PCR product as
expected. All other lanes show an approximately 300 bp product
corresponding to the expected NEP reverse transcriptase–PCR product of
313 bp (base pairs 461–774).
epithelial structures such as nasal mucosa (Ohkubo et al, 1994),
pulmonary epithelium (Johnson et al, 1985; Borson, 1991), and
intestinal mucosa (Bunnett et al, 1993) have been shown by IHC
and/or in situ hybridization methods to express NEP. In support
of our results, previous studies of whole skin homogenates have
shown NEP enzymatic activity in mice (Paus et al, 1994), guinea
pigs (Iwamoto et al, 1989; Rubenstein et al, 1990), and humans
(Bou-Gharios et al, 1995) but the anatomic localization of this
activity was not described. Bou-Gharios et al (1995) showed NEP
enzyme activity in human fibroblasts taken from patients with
scleroderma but not from tissue sections by IHC. We also detected
NEP in fibroblasts by northern blotting but did not observe staining
by IHC in normal skin or wounds. One possible explanation for
the difficulty in NEP localization by IHC is that the molecule is
extensively glycosylated. NEP expressed by different cells may be
glycosylated differently (Braun et al, 1984) and glycosylation may
influence epitope recognition by IHC. In our studies of wounds,
one must invoke such an explanation to account for the observation
that the fibroblasts in the wound bed do not stain by IHC while
keratinocytes and endothelial cells do stain. All three cell lines in
culture can be demonstrated by northern blot analysis to express
mRNA for NEP and, in our studies, fibroblasts expressed the
highest level. Alternatively, cell culture may differ from the wound
environment regarding stimulation of NEP expression in fibroblasts.
An explanation for localization of NEP to the basal layer of
keratinocytes is not immediately apparent. Nerve filaments have
been observed throughout the epidermis (Hilliges et al, 1995). NEP
staining in a basal pattern has, however, been previously described
in nasal mucosa (Ohkubo et al, 1994) and the lung (Nadel and
Borson, 1991). The explanation may reside with localization of
neuropeptide receptor expression, although this has not been
Figure 10. NEP mRNA is detected by northern blot analysis in human
keratinocytes, human dermal fibroblasts (HDF), and human dermal
microvascular endothelial cells (HDMEC). NEP mRNA expression is
demonstrated in human keratinocytes, HDF and HDMEC derived from
human foreskins. NEP mRNA expression (3.1 kb) was measured by
northern blot analysis with or without the addition of 100 nM SP for 3 h
to cultured human keratinocytes, HDF and HDMEC. Actin mRNA levels
were measured to determine relative loading of RNA. The height of the
bars is based on the percentage expression of NEP mRNA relative to
β-actin.
studied in skin. The tachykinin receptors and NEP are coexpressed
in many tissues, including the central nervous system (Waksman
et al, 1986), the airways (Kummer et al, 1990; Kummer and Fischer,
1991), and the gastrointestinal track (Bunnett et al, 1993). Epithelial
cells transfected with cDNA encoding NEP and/or SP receptor
(SPR), effectively downregulate the interaction between SP and
SPR only when NEP is colocalized on the same cell as SPR
(Okamoto et al, 1994). Competition between receptors and degrad-
ative enzymes for neuropeptides may best explain the pattern of
location for NEP observed in the epidermis. We hypothesize that
the SPR is concentrated on the same cells that express NEP in the
epidermis, but this has not yet been studied. Naturally, as noted
above, we must also consider the possibility that the differential
IHC staining in the epidermis and in wounds may be related to
differential glycosylation of the NEP protein with masking of the
antigenic site under certain conditions.
The hair follicles deserve separate mention. In 1994 Paus et al
demonstrated hair growth induction by SP in mice during the
telogen phase of the hair cycle. They also showed hair cycle-
dependent activity of NEP. Our work demonstrates the presence
of NEP in human follicles. Although we were not able to detect
any difference in staining pattern of telogen versus anagen follicles
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in this limited sample, the differential staining of inner root sheath
in terminal versus vellus follicles and the staining of follicular stela
is intriguing and deserves further study. One could speculate that
different follicles might be induced or maintained, at least in part
by neural regulation.
In wound healing, one would expect neuropeptides to be one
of the earliest signals present in the wound environment. The cells
that mediate the cutaneous repair process including keratinocytes,
fibroblasts, endothelial cells, and inflammatory cells are responsive
to SP (Ansel et al, 1996). The presence of NEP in the wound
environment would downregulate the trophic effects of neuro-
peptides on the cells in the wound.
The full thickness staining pattern of the new wound epithelium
and the adjacent ‘‘transition epithelium’’ at the pre-existing wound
margin is unexplained. One could speculate about the importance
of these cells in the secretion of NEP in the wound environment
or possibly, the coexpression of NEP in cells with upregulated
neuropeptide receptor expression.
At 1 h after an incisional wound, no change in the pattern of
expression of NEP is seen at the epithelial wound margin and no
NEP staining is present in the provisional wound matrix. By 6 h,
only the basal cells express NEP in the epidermis but staining is
also present in the provisional wound matrix. It has been previously
shown that human fibroblasts in culture take approximately 1 h to
begin synthesizing mature NEP (Lorkowski et al, 1987). NEP
staining is consistently observed in the wound matrix after 6 h and
it appears to be largely associated with extracellular matrix. While
NEP is generally thought of as a membrane bound metalloendo-
peptidase, it has been shown to be secreted in certain physiologic
fluids such as plasma, cerebrospinal fluid, amniotic fluid, and seminal
plasma (Spillantini et al, 1990). The concentration of NEP seems
to increase during inflammatory processes in the synovial fluid
(Appelboom et al, 1991) and in the respiratory secretions in
sarcoidosis and adult respiratory distress syndrome (Johnson et al,
1985). Frog skin has been shown to secrete a 100 kDa metalloendo-
peptidase, distinct from NEP, which is thought to be a prototype
of the metalloendopeptidase family (Carvalho et al, 1992).
In summary, we have demonstrated the localization of NEP
expression in human skin and in partial thickness cutaneous wounds.
We speculate that neuroinflammation may play an important
part in wound healing. Patients with diabetes1 or spinal cord
injuries2exhibit a decreased number of neuropeptide-containing
nerves and show impaired wound healing. It will be of interest to
study expression of NEP, neuropeptide, and neuropeptide receptors
in such patients. Likewise, it will be of interest to study these
mediators of neuroinflammation in a variety of inflammatory skin
diseases such as psoriasis, atopic dermatitis, and hair disorders.
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